Semaglutide Microdosing Schedule: What to Understand

"Microdosing" has become a popular way to describe using smaller-than-standard amounts of a GLP-1 medication like semaglutide. People are usually curious about a schedule: how often to inject, how the amount changes over time, and how to keep things gentle. This guide explains the concepts in plain English so you can have a better-informed conversation with a licensed clinician. It is educational only and is not medical advice or a prescription.

What "microdosing" actually means

Semaglutide has standard, studied dose ranges for the FDA-approved branded products, and those products come with official titration schedules. When people say "microdosing," they generally mean using amounts below the typical starting or maintenance doses — often to reduce side effects, to ease into treatment slowly, or to maintain results with a smaller amount. Importantly, microdosing is not an FDA-recognized protocol; it's a community term. The safe, studied path is the labeled titration overseen by a prescriber.

Because semaglutide has a long half-life (roughly a week), it's typically injected once weekly. That weekly rhythm is the backbone of almost any schedule, whether standard or reduced. Some people ask about splitting a weekly amount into smaller, more frequent injections; there isn't strong published evidence that this changes outcomes, and it introduces more room for measurement error.

Why titration is the real story

The single most important idea in any GLP-1 schedule is slow titration. The approved products start low specifically to let the gut adjust, which reduces nausea, reflux, and fatigue. A "microdosing schedule" is really just a philosophy of starting even lower and increasing even more gradually — for example, holding a small amount for several weeks before considering any increase, and only moving up if tolerated and if a clinician agrees it's appropriate.

A few principles people commonly discuss:

• One change at a time. Adjust the amount, then wait long enough (often 4+ weeks) to judge tolerance and effect before changing again.
• Stability over speed. Many people find a modest amount they tolerate well and simply stay there, rather than chasing the highest dose.
• Track everything. Nausea, appetite, weight, energy, and hydration are all worth logging. A simple dose tracker makes patterns easier to see over weeks and months.

The measurement problem

Smaller amounts are harder to measure accurately, and this is where mistakes happen. If semaglutide is reconstituted, the concentration you mix determines how many units on a syringe equal your intended amount. Getting this math wrong — in either direction — is a real safety risk. Two tools can help you sanity-check your thinking before you talk to a clinician: our semaglutide dosage calculator and the reconstitution calculator, which shows how volume and concentration relate. If you get confused by "units," the semaglutide unit conversion guide walks through the syringe-marking arithmetic.

None of these tools decide a dose for you. They help you understand the numbers so you can verify a plan with the person who is legally and clinically responsible for your care.

A conceptual example of a gentle schedule

To illustrate the shape of a slow schedule — not a prescription — many gradual approaches look something like this: a small weekly amount held for several weeks, a small step up only if well tolerated, another hold period, and so on, with long plateaus rather than quick jumps. The exact numbers should come from a clinician who knows your history, other medications, and goals. The takeaway is the pattern: start low, go slow, hold long, adjust rarely.

Side effects and when to slow down

Common GLP-1 side effects include nausea, constipation or diarrhea, reduced appetite, fatigue, and occasional reflux. Most are dose-related and often improve as the body adapts. Part of the appeal of a microdosing mindset is minimizing these. If side effects are significant, the usual response is to pause increases (or step back down) and check in with a prescriber — not to push through. Warning signs like severe abdominal pain, persistent vomiting, or signs of dehydration warrant prompt medical attention.

There are also situations where GLP-1 medications aren't appropriate — certain thyroid cancer history, pancreatitis history, pregnancy, and interactions with other drugs. This is exactly why a licensed clinician needs to be in the loop.

How semaglutide compares to related compounds

People exploring GLP-1 options often compare notes across compounds. Tirzepatide has its own titration considerations — you can read about a lower-dose approach in our microdosing tirzepatide guide. Newer molecules like retatrutide and cagrilintide are frequently discussed online, but it's important to be clear: these are investigational and are not FDA-approved as finished drugs. The same goes for research peptides like tesamorelin in unapproved forms. Any use of investigational compounds should happen only under a licensed clinician's supervision, and much of what circulates online lacks the safety data that approved products have.

Bringing it together

A "semaglutide microdosing schedule" is best understood as a slow, conservative version of standard titration: weekly injections, small amounts, long hold periods, careful tracking, and frequent check-ins. The tools and guides on PeptideDraw exist to help you understand the numbers and ask sharper questions — not to replace a prescriber. Browse the full guides library if you want to go deeper on reconstitution, injection sites, and comparisons. Whatever you do, make a licensed clinician your partner in the plan.